ArticleResearch and reports in urology2017

Degarelix treatment is compatible with diabetes and antithrombotic therapy in patients with prostate cancer.

Suguru Tokiwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.